Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

We conducted a prospective randomized phase II study to evaluate two chemotherapy regimens: (i) rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone (R-HCVAD) alternating with rituximab, high-dose methotrexate, and cytarabine (R-MA) and (ii) rituximab, cyclop...

詳細記述

保存先:
書誌詳細
出版年:Br J Haematol
主要な著者: Oki, Yasuhiro, Westin, Jason R., Vega, Francisco, Chuang, Hubert, Fowler, Nathan, Neelapu, Sattva, Hagemeister, Fredrick B., McLaughlin, Peter, Kwak, Larry W., Romaguera, Jorge E., Fanale, Michelle, Younes, Anas, Rodriguez, Maria Alma, Orlowski, Robert Z., Wang, Michael, Ouzounian, Souzanne T., Samaniego, Felipe, Fayad, Luis
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278952/
https://ncbi.nlm.nih.gov/pubmed/24117234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12585
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料